Abstract:Ischemic stroke (IS) is a detrimental neurological disease with limited treatments options. Astragaloside IV (As‐IV) was a promising bioactive constituent in the treatment of IS. In our study, As‐IV promoted the transcription of fat mass and obesity‐associated (Fto) by upregulating activating transcription factor 3(Atf3), resulting in a decrease of long‐chain acyl‐CoA synthetase‐4 (Acsl4) N6‐methyladenosine (m6A) levels, thus improving neuronal injury in IS by inhibiting ferroptosis. These findings provided a better understanding of the molecular mechanisms underlying the neuroprotective effects of As‐IV and led to novel therapeutic targets for the treatment of IS. Ischemic stroke (IS) is a detrimental neurological disease with limited treatment options. Astragaloside IV (As‐IV) was a promising bioactive constituent in the treatment of IS. However, the functional mechanism remains unclear. Here, IS cell and mouse models were established by oxygen glucose deprivation/re‐oxygenation (OGD/R) and middle cerebral artery occlusion (MCAO). Quantitative reverse transcription PCR (RT–qPCR), Western blotting, or Immunofluorescence staining measured related gene and protein expression of cells or mice brain tissues, and the results revealed altered expression of acyl‐CoA synthetase long‐chain family member 4 (Acsl4), fat mass and obesity‐associated (Fto), and activation transcription factor 3 (Atf3) after treatment with As‐IV. Then, increased N6‐methyladenosine (m6A) levels caused OGD/R or MCAO were reduced by As‐IV according to the data from methylated RNA immunoprecipitation (MeRIP)‐qPCR and dot blot assays. Moreover, through a series of functional experiments such as observing mitochondrial changes under transmission electron microscopy (TEM), evaluating cell viability by cell counting kit‐8 (CCK‐8), analyzing infract area of brain tissues by 2,3,5‐triphenyltetrazolium chloride (TTC) staining, measuring levels of malondialdehyde (MDA), lactate dehydrogenase (LDH), Fe2+, solute carrier family 7 member 11 (Slc7a11) and glutathione peroxidase 4 (Gpx4) and concentration of glutathione (GSH), we found that Fto knockdown, Acsl4 overexpression or Atf3 knockdown promoted the viability of OGD/R cells, inhibited cell ferroptosis, reduced infract size, while As‐IV treatment or Fto overexpression reversed these changes. In mechanism, the interplays of YTH N6‐methyladenosine RNA‐binding protein 3 (Ythdf3)/Acsl4 and Atf3/Fto were analyzed by RNA‐pull down, RNA immunoprecipitation (RIP), chromatin immunoprecipitation (ChIP) and dual‐luciferase reporter assay. Fto regulated the m6A levels of Acsl4. Ythdf3 bound to Acsl4, and modulated its levels through m6A modification. Atf3 bound to Fto and positively regulated its levels. Overall, As‐IV promoted the transcription of Fto by upregulating Atf3, resulting in decreased m6A levels of Acsl4, thus, improving neuronal injury in IS by inhibiting ferroptosis.

Lactylation of nuclear receptor coactivator 4 promotes ferritinophagy and glycolysis of neuronal cells after cerebral ischemic injury

Nuclear Receptor Coactivator 4-Mediated Ferritinophagy Contributes to Cerebral Ischemia-Induced Ferroptosis in Ischemic Stroke.

Regulating NCOA4-Mediated Ferritinophagy for Therapeutic Intervention in Cerebral Ischemia-Reperfusion Injury

Inhibition of Acyl-CoA Synthetase Long-Chain Family Member 4 Facilitates Neurological Recovery After Stroke by Regulation Ferroptosis

Oxidative medicine and cellular longevity the role and mechanism of NCOA4 in ferroptosis induced by intestinal ischemia reperfusion

Ring Finger Protein 146-mediated Long-chain Fatty-acid-Coenzyme a Ligase 4 Ubiquitination Regulates Ferroptosis-induced Neuronal Damage in Ischemic Stroke

Cgas-Sting Pathway Aggravates Early Cerebral Ischemia-Reperfusion Injury in Mice by Activating NCOA4-mediated Ferritinophagy.

Global-Scale Profiling of Differential Expressed Lysine-Lactylated Proteins in the Cerebral Endothelium of Cerebral Ischemia–Reperfusion Injury Rats

β-1,4-Galactosyltransferase 1 protects against cerebral ischemia injury in mice by suppressing ferroptosis via the TAZ/Nrf2/HO-1 signaling pathway

ACSL4 Exacerbates Ischemic Stroke by Promoting Ferroptosis-Induced Brain Injury and Neuroinflammation

Astrocyte-derived lactate aggravates brain injury of ischemic stroke in mice by promoting the formation of protein lactylation

Ferritin reduction is essential for cerebral ischemia-induced hippocampal neuronal death through p53/SLC7A11-mediated ferroptosis

Mechanism of acupuncture in attenuating cerebral ischaemia-reperfusion injury based on nuclear receptor coactivator 4 mediated ferritinophagy

Abstract TP283: Histone Lactylation and Neuronal Autophagy: Insights Into the Penumbra-Core Transition and Potential Biomarker in Ischemic Stroke

Cerebral ischemia induced iron deposit, ferritin accumulation, nuclear receptor coactivator 4-depletion and ferroptosis.

Reduction of lactoferrin aggravates neuronal ferroptosis after intracerebral hemorrhagic stroke in hyperglycemic mice

Astragaloside IV alleviates neuronal ferroptosis in ischemic stroke by regulating fat mass and obesity‐associated—N6‐methyladenosine—acyl‐CoA synthetase long‐chain family member 4 axis

Melatonin improves stroke by inhibiting autophagy-dependent ferroptosis mediated by NCOA4 binding to FTH1

Abstract WP233: Histone Lactylation in Neuronal Mitochondria Fission: Implications for Stress-Exacerbated Ischemic Stroke Outcomes

Abstract TP289: Protein Lactylation Regulation in Ischemic Stroke: Role of MeCP2 Lactylation in Repressing Apoptosis-Associated Gene Transcription

Histone Demethylase KDM4A Inhibition Represses Neuroinflammation and Improves Functional Recovery in Ischemic Stroke